9 Feb 2022 , 08:13 AM
Net profit of Astrazeneca Pharma India declined 45.75% to Rs 11.42 crore in the quarter ended December 2021 as against Rs 21.05 crore during the previous quarter ended December 2020. Sales rose 0.14% to Rs 200.53 crore in the quarter ended December 2021 as against Rs 200.25 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 200.53 | 200.25 | 0 |
| OPM % | 7.32 | 15.35 | – |
| PBDT | 19.78 | 33.41 | -41 |
| PBT | 16.27 | 28.30 | -43 |
| NP | 11.42 | 21.05 | -46 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
